Construction of a reference material panel for detecting KRAS/NRAS/EGFR/BRAF/MET mutations in plasma ctDNA.

Jun XuShoufang QuNan SunWenxin ZhangJuanli ZhangQingtao SongMufei LinWei GaoQiaosong ZhengMipeng HanChenglong NaRen XuXiaoyan ChangXue-Xi YangJie Huang

Published in: Journal of clinical pathology (2020)

RM for a KRAS/NRAS/EGFR/BRAF/MET mutation panel for plasma ctDNA was developed, which will be essential for quality control of the performance of independent laboratories.

Keyphrases

wild type
tyrosine kinase
quality control
epidermal growth factor receptor
small cell lung cancer
circulating tumor
high density